Moneycontrol PRO
HomeNewsLincolnpharmaceuticals

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Hot Stocks | Double-digit returns from Lincoln Pharma, Globus Spirits, Dalmia Bharat possible in short term. Here's why

    Nandish Shah of HDFC Securities believes that short-term trend of the Nifty is weak. Therefore, his advice is to remain cautious till the Nifty closes above the 17,250 levels.

  • Lincoln Pharma surges 20%; what's driving the stock up?

    Lincoln Pharma surges 20%; what's driving the stock up?

    The research house cites the company‘s capability to increase market share by widening portfolio through product launches, expanding geographies and undertaking large job contracts.

  • Here are a few investment ideas from Prakash Diwan

    Here are a few investment ideas from Prakash Diwan

    In an interview to CNBC-TV18, Prakash Diwan, Investment Evangelist at prakashdiwan.in shared his readings and outlook on specific stocks and sectors.

  • Exit Lincoln Pharma, prefer Syngene: Gaurang Shah

    Exit Lincoln Pharma, prefer Syngene: Gaurang Shah

    Gaurang Shah of Geojit BNP Paribas Financial Services is of the view that one may exit Lincoln Pharma.

  • Bull's Eye: Buy SpiceJet, KPIT, I'bulls Real; sell UPL, HDIL

    Bull's Eye: Buy SpiceJet, KPIT, I'bulls Real; sell UPL, HDIL

    Krish Subramanyam of Altamount Capital is of the view that one may buy Apollo Tyres with a target of Rs 141.

  • Bull's Eye: Buy Ceat, JK Paper, EIH, KPIT; sell BEML, BoI

    Bull's Eye: Buy Ceat, JK Paper, EIH, KPIT; sell BEML, BoI

    Krish Subramanyam of Altamount Capital advises buying Triveni Engineering with a target of Rs 41.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347